Tumor-associated stromal gene expression signatures predict therapeutic response to erlotinib/bevacizumab in non-small cell lung cancer (NSCLC)

被引：0
|
作者：
Franzini, Anca
Durr, Oliver
Baty, Florent
Brutsche, Martin
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2014年 / 44卷
关键词：
Epithelial cell; Genetics; Cell biology;
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
P821
引用
收藏
页数：4
相关论文
共 50 条
  • [21] VeriStrat® classifier for survival and time to progression in non-small cell lung cancer (NSCLC) patients treated with erlotinib and bevacizumab
    Carbone, David P.
    Salmon, J. Stuart
    Billheimer, Dean
    Chen, Heidi
    Sandler, Alan
    Roder, Heinrich
    Roder, Joanna
    Tsypin, Maxim
    Herbst, Roy S.
    Tsao, Anne S.
    Tran, Hai T.
    Dang, Thao P.
    LUNG CANCER, 2010, 69 (03) : 337 - 340
  • [22] Single-cell combined mutation and gene expression studies of circulating tumor-associated cells in non-small cell lung cancer
    Mong, J.
    Shi, J.
    Chin, T. M.
    Wong, S-W.
    Tee, A.
    Chan, D.
    Wong, K.
    Yeap, S.
    Ngo, L.
    Tan, Y-O.
    Hu, M.
    Ying, J.
    Tan, M-H.
    ANNALS OF ONCOLOGY, 2017, 28
  • [23] Characterization of human non-small cell lung cancer (NSCLC) cell lines for expression of MHC, co-stimulatory molecules and tumor-associated antigens
    Wroblewski, JM
    Bixby, DL
    Borowski, C
    Yannelli, JR
    LUNG CANCER, 2001, 33 (2-3) : 181 - 194
  • [24] MALDI-TOF mass spectrometry proteomic profiling to discriminate response to the combination of bevacizumab and erlotinib in non-small cell lung cancer (NSCLC).
    Salmon, JS
    Sandler, A
    Billheimer, D
    Herbst, RS
    Tran, HT
    Tsao, A
    Dang, TP
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 626S - 626S
  • [25] Economic evaluation of bevacizumab in the treatment of non-small cell lung cancer (NSCLC)
    Chien, Chun-Ru
    Shih, Ya-Chen Tina
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2012, 4 : 201 - 208
  • [26] Tumor-Associated Macrophages: Key Players in the Non-Small Cell Lung Cancer Tumor Microenvironment
    Lv, Tongtong
    Fan, Rui
    Wu, Jiaqi
    Gong, Haolan
    Gao, Xiaoru
    Liu, Xin
    Gong, Yixin
    Luo, Bo
    Zhang, Yanhua
    Peng, Xiaochun
    Liang, Gai
    CANCER MEDICINE, 2025, 14 (03):
  • [27] Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer
    Gentles, Andrew J.
    Bratman, Scott V.
    Lee, Luke J.
    Harris, Jeremy P.
    Feng, Weiguo
    Nair, Ramesh V.
    Shultz, David B.
    Nair, Viswam S.
    Hoang, Chuong D.
    West, Robert B.
    Plevritis, Sylvia K.
    Alizadeh, Ash A.
    Diehn, Maximilian
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (10):
  • [28] Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer
    X Yan
    S-C Jiao
    G-Q Zhang
    Y Guan
    J-L Wang
    Cancer Gene Therapy, 2017, 24 : 57 - 63
  • [29] Tumor-associated immune factors are associated with recurrence and metastasis in non-small cell lung cancer
    Yan, X.
    Jiao, S-C
    Zhang, G-Q
    Guan, Y.
    Wang, J-L
    CANCER GENE THERAPY, 2017, 24 (02) : 57 - 63
  • [30] Harmonization radiomics models to predict tumor response in non-small cell lung cancer (NSCLC) patients treated with immunotherapy
    Yadav, Monica
    Lee, Jeeyeon
    Kim, Peter Haseok
    Lee, Seyoung
    Um, Taegyu
    Lee, Salie
    Chuchuca, Maria Jose
    Djunadi, Trie Arni
    Chung, Liam Il-Young
    Yu, Jisang
    Rodrigues, Darren
    Gennaro, Nicolo
    Kim, Leeseul
    Nam, Myungwoo
    Oh, Youjin
    Yoon, Sungmi
    Shah, Zunairah
    Kim, Yuchan
    Hong, Ilene
    Jang, Jessica
    Kang, Grace
    Cho, Amy
    Lee, Soowon
    Hong, Timothy
    Nam, Cecilia
    Velichko, Yury S.
    Chae, Young Kwang
    CANCER RESEARCH, 2024, 84 (06)
12345